Wanchaijiraboon, P.; Teeyapun, N.; Pakvisal, N.; Sainamthip, P.; Susiriwatananont, T.; Zungsontiporn, N.; Suntronwong, N.; Vichaiwattana, P.; Klinsawat, W.; Wanlapakorn, N.;
et al. Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment. Vaccines 2022, 10, 1662.
https://doi.org/10.3390/vaccines10101662
AMA Style
Wanchaijiraboon P, Teeyapun N, Pakvisal N, Sainamthip P, Susiriwatananont T, Zungsontiporn N, Suntronwong N, Vichaiwattana P, Klinsawat W, Wanlapakorn N,
et al. Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment. Vaccines. 2022; 10(10):1662.
https://doi.org/10.3390/vaccines10101662
Chicago/Turabian Style
Wanchaijiraboon, Passakorn, Nattaya Teeyapun, Nussara Pakvisal, Panot Sainamthip, Thiti Susiriwatananont, Nicha Zungsontiporn, Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Worata Klinsawat, Nasamon Wanlapakorn,
and et al. 2022. "Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment" Vaccines 10, no. 10: 1662.
https://doi.org/10.3390/vaccines10101662
APA Style
Wanchaijiraboon, P., Teeyapun, N., Pakvisal, N., Sainamthip, P., Susiriwatananont, T., Zungsontiporn, N., Suntronwong, N., Vichaiwattana, P., Klinsawat, W., Wanlapakorn, N., Tanasanvimon, S., Sriuranpong, V., Poovorawan, Y., & Luangdilok, S.
(2022). Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment. Vaccines, 10(10), 1662.
https://doi.org/10.3390/vaccines10101662
